Biohaven (BHVN) Net Cash Flow (2021 - 2026)

Biohaven has reported Net Cash Flow for 6 years, with the latest figure at $44.3 million in Q1 2026.

• Quarterly Net Cash Flow rose 35633.87% year-over-year to $44.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $174.4 million (up 306.8% YoY) and the FY2025 annual result came in at $130.2 million, up 187.03% from the prior year.
• Net Cash Flow held at $44.3 million in Q1 2026 per BHVN's latest filing, from $44.4 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $190.8 million in Q4 2022 and troughed at -$154.3 million in Q3 2024.
• A 5-year average of $11.8 million and a median of $14.4 million in 2024 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2026: Net Cash Flow tumbled 376.48% in 2023, then jumped 35633.87% in 2026.
• Over 5 years, Net Cash Flow stood at $190.8 million in 2022, then tumbled by 33.72% to $126.4 million in 2023, then sank by 88.58% to $14.4 million in 2024, then jumped by 207.55% to $44.4 million in 2025, then declined by 0.19% to $44.3 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $44.3 million, $44.4 million, and $19.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.